S. Cyrus Khojasteh,Upendra A. Argikar,James P. Driscoll,Carley J. S. Heck,Lloyd King,Klarissa D. Jackson,Wenying Jian,Amit S. Kalgutkar,Grover P. Miller,Valerie Kramlinger,Ivonne M. C. M. Rietjens,Aaron M. Teitelbaum,Kai Wang,Cong Wei,Benjamin M. Johnson,Yue-Zhong Shu,Xiaoliang Zhuo,Nicholas A. Meanwell,Matthew A. Cerny,Amit S. Kalgutkar,R. Scott Obach,Raman Sharma,Douglas K. Spracklin,Gregory S. Walker,Laura Goracci,Jenny Desantis,Aurora Valeri,Beatrice Castellani,Michela Eleuteri,Gabriele Cruciani,Manjinder S. Lall,Asser Bassyouni,James Bradow,Maria Brown,Mark Bundesmann,Jinshan Chen,Gregory Ciszewski,Anne E. Hagen,Dennis Hyek,Stephen Jenkinson,Bo Liu,R. Scott Obach,Senliang Pan,Usa Reilly,Neal Sach,Daniel J. Smaltz,Douglas K. Spracklin,Jeremy Starr,Melissa Wagenaar,Gregory S. Walker,Christina de Bruyn Kops,Martin Sicho,Angelica Mazzolari,Johannes Kirchmair,Porntipa Korprasertthaworn,Nuy Chau,Pramod C. Nair,Andrew Rowland,John O. Miners,Stephen T. Wrobleski,Ryan Moslin,Shuqun Lin,Yanlei Zhang,Steven Spergel,James Kempson,John S. Tokarski,Joann Strnad,Adriana Zupa-Fernandez,Lihong Cheng,David Shuster,Kathleen Gillooly,Xiaoxia Yang,Elizabeth Heimrich,Kim W. McIntyre,Charu Chaudhry,Javed Khan,Max Ruzanov,Jeffrey Tredup,Dawn Mulligan,Dianlin Xie,Huadong Sun,Christine Huang,Celia D'Arienzo,Nelly Aranibar,Manoj Chiney,Anjaneya Chimalakonda,William J. Pitts,Louis Lombardo,Percy H. Carter,James R. Burke,David S. Weinstein,Jing Li,Ju Liu,Jennifer Enders,Michael Arciprete,Chris Tran,Krishna Aluri,Li-Hua Guan,Jonathan O'Shea,Anna Bisbe,Klaus Charisse,Ivan Zlatev,Diana Najarian,Yuanxin Xu,Jaeah Kim,Noha M. El Zahar,Michael G. Bartlett,Kishore Katyayan,Ping Yi,Scott Monk,Kenneth Cassidy,Ryan H. Takahashi,Jessica M. Grandner,Sudheer Bobba,Yanzhou Liu,Paul Beroza,Donglu Zhang,Shuguang Ma,Noah Post,Rosie Yu,Sarah Greenlee,Hans Gaus,Eunju Hurh,John Matson,Yanfeng Wang,Yuya Tajima,Takeshi Toyoda,Yuichiro Hirayama,Kohei Matsushita,Takanori Yamada,Kumiko Ogawa,Kenji Watanabe,Takeji Takamura-Enya,Yukari Totsuka,Keiji Wakabayashi,Noriyuki Miyoshi,Jiayin Zhang,Chi-Kong Chan,Yat-Hing Ham,Wan Chan,Mary Alexandra Schleiff,Noah R. Flynn,Sasin Payakachat,Benjamin Mark Schleiff,Anna O. Pinson,Dennis W. Province,S. Joshua Swamidass,Gunnar Boysen,Grover P. Miller,Dasean T. Nardone-White,Jennifer E. Bissada,Arsany A. Abouda,Klarissa D. Jackson,Zhuming Zhang,Peter J. Connolly,Heng Keang Lim,Vineet Pande,Lieven Meerpoel,Christopher Teleha,Jonathan R. Branch,Janine Ondrus,Ian Hickson,Tammy Bush,Leopoldo Luistro,Kathryn Packman,James R. Bischoff,Salam Ibrahim,Christopher Parrett,Yolanda Chong,Marco M. Gottardis,Gilles Bignan,Teresa Mulder,Sudder Bobba,Kevin M. Johnson,Jessica M. Grandner,Wei Wang,Chenghong Zhang,Jingwei Cai,Edna F. Choo,S. Cyrus Khojasteh,Donglu Zhang,Chenghong Zhang,James J. Crawford,Matthew L. Landry,Huifen Chen,Jane R. Kenny,S. Cyrus Khojasteh,Wendy Lee,Shuguang Ma,Wendy B. Young,Timon Geib,Madhuranayaki Thulasingam,Jesper Z. Haeggstrom,Lekha Sleno,James J. Monroe,Keith Q. Tanis,Alexei A. Podtelezhnikov,Truyen Nguyen,Sam V. Machotka,Donna Lynch,Raymond Evers,Jairam Palamanda,Randy R. Miller,Todd Pippert,Tamara D. Cabalu,Timothy E. Johnson,Amy G. Aslamkhan,Wen Kang,Alex M. Tamburino,Kaushik Mitra,Nancy G. B. Agrawal,Frank D. Sistare

Abstract:This annual review is the sixth of its kind since 2016 (see references). Our objective is to exploreand share articles which we deem influential and significant in the field of biotransformation andbioactivation. These fields are constantly evolving with new molecular structures and discoveriesof corresponding pathways for metabolism that impact relevant drug development with respectto efficacy and safety. Based on the selected articles, we created three sections: (1) drug design,(2) metabolites and drug metabolizing enzymes, and (3) bioactivation and safety (Table 1). Unlikein years past, more biotransformation experts have joined and contributed to this effort whilestriving to maintain a balance of authors from academic and industry settings.

Bioactivation and reactivity research advances – 2023 year in review

Novel advances in biotransformation and bioactivation research-2020 year in review

Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques

Development of novel tools for the in vitro investigation of drug-induced liver injury

Metabolism of new drug modalities research advances - 2023 year in review

Insights into Mechanisms and Severity of Drug-Induced Liver Injury Via Computational Systems Toxicology Approach.

Insights gained into the injury mechanism of drug and herb induced liver injury in the hepatic microenvironment

Toxicogenomics of drug induced liver injury – from mechanistic understanding to early prediction.

Novel Clinical Biomarkers for Drug-Induced Liver Injury.

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment

A Chemoproteomic Platform to Assess Bioactivation Potential of Drugs

[Promoting Translational Research on Drug-Induced Liver Injury].

Dissecting the molecular pathophysiology of drug-induced liver injury

Research advances in the pathogenesis of drug-induced liver injury

Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury

Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure

Overview of Research on Drug-induced Liver Injury

Industry Review of Best Practices for Risk Management of Drug-Induced Liver Injury from Development to Real-World Use

Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]

Metabolite biomarkers of drug-induced liver injury

Research advances in drug-induced liver injury and existing problems in China